Andrew McLachlan

Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

A. Gross, N. Wong Doo, Josephine Adattini, 2022, Pharmacology research & perspectives.

Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot study

D. Currow, M. Lovell, B. Fazekas, 2023, BMJ Open.

Efficacy, safety, and dose‐dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta‐analysis

F. Stanaway, F. Blyth, R. Day, 2022, The Medical journal of Australia.

Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews

R. Day, N. Finnerup, M. Underwood, 2023, BMJ.

OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain—a statistical analysis plan

R. Day, B. Koes, J. Latimer, 2022, Trials.

OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain—a statistical analysis plan

R. Day, B. Koes, J. Latimer, 2022, Trials.

General practitioners’ decision-making process to prescribe pain medicines for low back pain: a qualitative study

J. Zadro, C. Abdel Shaheed, G. Ferreira, 2023, BMJ Open.

A Second Look at the Risks of Serious Adverse Events with Orthopaedic Manual Therapy, Paracetamol, and NSAID Treatment of Neck Pain.

C. Maher, Andrew McLachlan, C. A. Shaheed, 2023, The Journal of orthopaedic and sports physical therapy.

Pilot Clinical and Pharmacokinetic Study of Δ9-Tetrahydrocannabinol and Cannabidiol Oro-Buccal Spray in Advanced Cancer with Uncontrolled Pain.

L. Vitetta, J. Henson, B. Butcher, 2020 .